Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 2	2025-11-19		NCT06532552

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Jining Medical University	15
Qilu Hospital of Shandong University	249
The Affiliated Hospital of Qingdao University	124
The First Affiliated Hospital of Anhui Medical University	85
The First Affiliated Hospital of Bengbu Medical University	47
The First Affiliated Hospital of Soochow University	164
Tongji Hospital	276

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affliated Hospital of Soochow University	Suzhou	China	8